a College of Veterinary Medicine , Chonbuk National University , Iksan , Republic of Korea.
Vet Q. 2017 Dec;37(1):81-90. doi: 10.1080/01652176.2017.1308040.
In the pathogenicity of porcine edema disease (ED), which is caused by the Escherichia coli-producing F18 and Shiga toxin, F18 fimbrial adhesins and Shiga toxin 2e (Stx2e) play pivotal roles in the colonization and enterotoxicity of this pathogen.
To develop a vaccine candidate against ED by combining three selected antigens of F18 E. coli.
Genetically engineered Salmonella Typhimurium (ST) ghosts that express Stx2eB, FedF, and FedA were individually inserted in a ghost plasmid cassette, and the resultant plasmids were transformed into an attenuated ST (JOL912). The individual expression of Stx2eB, FedF, and FedA in JOL912 was validated by using an immunoblotting assay.
Immunization of the ghosts in BALB/c mice led to a significant increase in antigen-specific secretory IgA and serum IgG. Significantly marked elevation of the CD3CD4 T cell subpopulation and lymphocyte proliferating activity in the primed splenocytes were also observed. Furthermore, mRNA of IL-4 and IFN-γ were highly upregulated in in vitro stimulated splenic T cells. Subsequently, the immunized mice showed significant protection efficacy against a lethal dose 50 of a virulent strain, resulting in approximately 85% and 92% survival rates in mice with a single- and double-dose immunization, respectively, compared to only 40% of the non-immunized controls.
A mixture of the ghosts expressing these three antigens is a potential vaccine candidate for protection against the porcine edema disease.
在由产 F18 和志贺毒素的大肠杆菌引起的猪水肿病(ED)的致病性中,F18 菌毛黏附素和志贺毒素 2e(Stx2e)在该病原体的定植和肠毒性中发挥着关键作用。
通过组合三种选定的 F18 大肠杆菌抗原,开发针对 ED 的疫苗候选物。
将表达 Stx2eB、FedF 和 FedA 的基因工程化鼠伤寒沙门氏菌(ST)幽灵分别插入幽灵质粒盒中,然后将所得质粒转化为减毒 ST(JOL912)。使用免疫印迹法验证 JOL912 中 Stx2eB、FedF 和 FedA 的单独表达。
在 BALB/c 小鼠中免疫幽灵导致抗原特异性分泌型 IgA 和血清 IgG 显著增加。在初免的脾细胞中,还观察到 CD3CD4 T 细胞亚群和淋巴细胞增殖活性的显著升高。此外,体外刺激的脾 T 细胞中 IL-4 和 IFN-γ 的 mRNA 高度上调。随后,免疫小鼠对致死剂量 50 的强毒菌株表现出显著的保护效力,与未免疫对照相比,单次和双剂量免疫的小鼠的存活率分别约为 85%和 92%,而仅为 40%。
表达这些三种抗原的混合物是预防猪水肿病的潜在疫苗候选物。